Sexual and Reproductive Health Matters is an esteemed open-access journal published by Taylor & Francis Ltd, dedicated to advancing the fields of obstetrics and gynecology as well as reproductive medicine. Since its transition to open access in 2019, the journal has provided a vital platform for disseminating cutting-edge research and innovative practices pertaining to sexual and reproductive health. With a commendable impact reflected by its categorization in the Q1 Quartile for both Obstetrics and Gynecology and Reproductive Medicine as per the 2023 rankings, it ranks prominently at #71 out of 209 in Obstetrics and Gynecology and #34 out of 90 in Reproductive Medicine on Scopus. This journal not only serves as a resource for researchers and practitioners in the United Kingdom but also has a global reach, inviting contributions that address critical issues related to sexual and reproductive health. Positioned at the forefront of current health science discourse, Sexual and Reproductive Health Matters is an essential read for anyone dedicated to improving health outcomes in this vital area.

Current HIV/AIDS Reports, published by Springer, is a distinguished scholarly journal that addresses critical developments in the field of HIV/AIDS research. As a leading publication within the Q1 quartiles for both Infectious Diseases and Virology, it serves as an essential platform for researchers and healthcare providers aiming to advance knowledge and practices related to HIV prevention, treatment, and care. With a commitment to publishing innovative studies, reviews, and clinical guidelines, this journal fosters a comprehensive understanding of the complexities surrounding HIV/AIDS. The journal enjoys a robust reputation, evidenced by its impressive Scopus rankings, including a rank of #69 in Infectious Diseases and #21 in Virology, placing it in the top echelons of its field. With an open-access model, *Current HIV/AIDS Reports* significantly enhances the accessibility of crucial research findings to a global audience, driving progress in HIV/AIDS knowledge and public health.

International Journal for Equity in Health, published by BMC, stands as a pivotal platform within the fields of Health Policy and Public Health, dedicated to advancing knowledge related to health equity and social justice in healthcare systems. With an impressive HIndex and consistently ranking in the Q1 quartile for both health policy and public health categories as of 2023, this journal not only highlights critical research but also positions itself among the top echelons of the academic community, holding a commendable Scopus rank of #27 out of 310 in Health Policy and #71 out of 665 in Public Health, Environmental, and Occupational Health. Since its inception in 2002, and as an Open Access journal, it has been committed to making impactful research widely accessible, fostering a collaborative dialogue among researchers, practitioners, and policymakers globally. Based in the United Kingdom, the journal invites comprehensive submissions that address pressing issues surrounding health equity, and aims to contribute to the formulation of effective health policies that can bridge disparities across diverse populations.

JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

Current HIV Research is a pivotal journal dedicated to the latest advancements in the field of HIV research, published by Bentham Science Publishers Ltd. With a commitment to disseminating high-quality research, this journal serves as a critical resource for researchers, healthcare professionals, and students interested in infectious diseases and virology. The journal has an ISSN of 1570-162X and an E-ISSN of 1873-4251, reflecting its commitment to contemporary digital scholarship. Given its publication history spanning from 2003 to 2024, the journal has continually provided insights and peer-reviewed articles that foster knowledge and innovation in HIV research. Although it currently holds a Q3 ranking in Infectious Diseases and a Q4 ranking in Virology, these rankings underscore its importance as an emerging platform for critical research dialogue. Despite not being an Open Access journal, 'Current HIV Research' ensures that cutting-edge studies reach relevant practitioners and contribute to ongoing discourse in the medical community. By fostering an informed approach to HIV and its implications, this journal is an invaluable asset to those committed to advancing their expertise in this crucial area of health science.

JOURNAL OF DRUG EDUCATION, published by SAGE Publications Inc, serves as a vital platform for disseminating research and scholarly articles in the fields of health education, medicine, and mental health, focusing on drug-related issues. With its history dating back to 1972 and an ongoing publication cycle through 2024, the journal aims to enrich professional practice and inform policy-making through rigorous research. Although it does not currently operate under an Open Access model, the journal holds respectable rankings, finding itself in the third quartile across multiple categories including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, as per the 2023 metrics. This evaluation signifies its contribution to the discourse surrounding drug education and public health albeit within a competitive landscape. Scholars, researchers, and practitioners in the field are encouraged to engage with and contribute to this important dialogue addressing drug-related challenges in contemporary society.

AIDS AND BEHAVIOR, published by SPRINGER/PLENUM PUBLISHERS, is a leading scholarly journal dedicated to the interdisciplinary study of HIV/AIDS, focusing particularly on the behavioral aspects of the epidemic. With an impressive impact factor reflected in its Q1 rankings across key categories including Infectious Diseases, Public Health, and Social Psychology, this journal serves as a vital resource for researchers, clinicians, and public health professionals. It encompasses a wide scope of research, from the psychosocial factors influencing HIV transmission to innovative interventions that promote safe practices. Although it does not offer open access, the journal's rigorous peer-review process ensures the dissemination of high-quality, impactful research. Covering data from 1997 to 2024, AIDS AND BEHAVIOR is positioned at the forefront of advancements in the field, making it an essential addition to any academic library and a must-read for those involved in combating HIV/AIDS.

HIV Research & Clinical Practice, published by Taylor & Francis Ltd, is an essential open-access journal dedicated to advancing the knowledge and understanding of HIV-related research and clinical practices. With an ISSN of 2578-7489 and E-ISSN 2578-7470, this acclaimed journal is committed to disseminating cutting-edge studies and innovative treatment strategies within the infectious diseases and pharmacology fields, achieving a commendable Q2 ranking in both categories as of 2023. The journal's scope encompasses a broad range of topics from basic science to clinical application, providing a vital platform for researchers, clinicians, and students to exchange insights and foster collaboration. As an open-access publication since 2022, it ensures that high-quality research is accessible to a global audience, encouraging a greater understanding of HIV and its implications for public health. With its base in the United Kingdom and a convergence period from 2019 to 2024, HIV Research & Clinical Practice stands at the forefront of the fight against HIV/AIDS, making significant contributions to the clinical community and beyond.

The JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, published by the NATL MED ASSOC, stands as a premier platform in the realm of medical research and discourse, with a rich history spanning from 1946 to 2024. With an impressive Q1 ranking in the field of Medicine (miscellaneous), this journal is dedicated to advancing knowledge across diverse subfields of medicine, making it a critical resource for researchers, practitioners, and students alike. Recognized for its significant impact, it holds a commendable position within the 83rd percentile of general medicine publications, ranked at #106 out of 636 by Scopus. Although currently lacking open access options, the journal continues to disseminate foundational research and innovative insights essential for driving progress in healthcare. Its commitment to quality publication reflects the high standards of the National Medical Association, ensuring that each article contributes meaningfully to the global healthcare community.

Journal of the International Association of Providers of AIDS Care, published by SAGE PUBLICATIONS INC, is a distinguished open-access journal dedicated to the field of HIV/AIDS care and research. Since its inception in 2002, the journal has provided an essential platform for the dissemination of high-quality, peer-reviewed scholarly articles that advance knowledge in exciting areas such as dermatology, immunology, and infectious diseases. With an impact factor that highlights its role in shaping ongoing discourse, the journal boasts a strong reputation, reflected in its Q1 status in Dermatology and consistent ranking in the top tiers for immunology and infectious diseases in the Scopus Ranks. This commitment to excellence ensures that researchers, healthcare professionals, and students have access to the latest advancements and best practices in HIV/AIDS prevention and care. As a pivotal resource in the global health landscape, the journal stands at the forefront of efforts to combat the challenges presented by this ongoing epidemic.